Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Resistance, Multiple, Bacterial”

111 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 111 results

Large-scale testing (Phase 3)Study completedNCT04062201
What this trial is testing

Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care

Who this might be right for
TuberculosisPre-XDR-TBExtensively Drug-Resistant Tuberculosis+2 more
Wits Health Consortium (Pty) Ltd 402
Large-scale testing (Phase 3)Ended earlyNCT01455246
What this trial is testing

Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis

Who this might be right for
CirrhosisAscitesNosocomial Spontaneous Bacterial Peritonitis
University of Padova 32
Early research (Phase 1)Study completedNCT03910673
What this trial is testing

Intravenous Fosfomycin Pharmacokinetics Study

Who this might be right for
Bacterial InfectionMultiple-drug ResistancePathogen Resistance
National Institute of Allergy and Infectious Diseases (NIAID) 39
Not applicableStudy completedNCT04698148
What this trial is testing

Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gastrointestinal Diseases

Who this might be right for
Clostridium Difficile InfectionMulti Drug Resistant OrganismsChronic Inflammatory Bowel Disease+2 more
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 225
Not applicableNot Yet RecruitingNCT07017803
What this trial is testing

Molecular Epidemiology, Strains Genotyping of Multi-drug Resistant Tuberculosis Circulating in Central Africa Region

Who this might be right for
Tuberculosis, Multi Drug ResistantStrainsMolecular Epidemiology+2 more
Centre de Recherche Médicale de Lambaréné 460
Not applicableStudy completedNCT06671808
What this trial is testing

HIV and Multi-Drug Resistant Tuberculosis: a Study on Clinical Outcomes

Who this might be right for
HIV InfectionMDR-TB
Zahedan University of Medical Sciences 222,128
Not applicableApproved For MarketingNCT01464762
What this trial is testing

Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA
Large-scale testing (Phase 3)WithdrawnNCT01600963
What this trial is testing

Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis

Who this might be right for
Multi-drug Resistant Tuberculosis
Janssen Infectious Diseases BVBA
Not applicableNot Yet RecruitingNCT06674291
What this trial is testing

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Korea Otsuka Pharmaceutical Co., Ltd. 222
Large-scale testing (Phase 3)Ended earlyNCT03580044
What this trial is testing

Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria

Who this might be right for
Serious Bacterial Infection
Pfizer 15
Large-scale testing (Phase 3)Study completedNCT02142751
What this trial is testing

Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli

Who this might be right for
Infection Due to ESBL Escherichia Coli
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 161
Not applicableStudy completedNCT03057756
What this trial is testing

Treatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug Resistance

Who this might be right for
Multi-drug Resistant Tuberculosis
Centre de Recherche Médicale de Lambaréné 23
Not applicableStudy completedNCT05378217
What this trial is testing

AMR-DetecTool for the Diagnostic of MDR Bacterial Infections

Who this might be right for
Bacterial Sensitivity TestsAntimicrobial Drug Resistance
Assistance Publique - Hôpitaux de Paris 167
Not applicableStudy completedNCT05303662
What this trial is testing

Prevalence of Multidrug Resistant Micro-organism Carriage in Patients Undergoing an ERCP in Four Different Countries

Who this might be right for
Drug Resistance, Multiple, BacterialCholangiopancreatography, Endoscopic Retrograde
Marco J. Bruno 1,244
Large-scale testing (Phase 3)Study completedNCT02454205
What this trial is testing

An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis

Who this might be right for
TuberculosisMultidrug Resistant TuberculosisExtensively-drug Resistant Tuberculosis
University of Cape Town 154
Large-scale testing (Phase 3)UnknownNCT04081077
What this trial is testing

PRACTECAL-PKPD Sub Study

Who this might be right for
Multi-drug Resistant TuberculosisExtensively Drug-Resistant TuberculosisPulmonary Tuberculosis
Medecins Sans Frontieres, Netherlands 240
Not applicableStudy completedNCT04812847
What this trial is testing

Multidrug Resistant Gram-negative Pathogen Infections in High Risk Neonates in the Northeast of Mexico

Who this might be right for
Infant Newborn Disease
Instituto Tecnologico y de Estudios Superiores de Monterey 597
Not applicableEnded earlyNCT04783727
What this trial is testing

PredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantBacterial Infections+1 more
Research Center Borstel 4
Testing effectiveness (Phase 2)Study completedNCT01498419
What this trial is testing

Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)

Who this might be right for
Pulmonary Tuberculosis
Global Alliance for TB Drug Development 207
Large-scale testing (Phase 3)Study completedNCT01817075
What this trial is testing

Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant

Who this might be right for
Bacterial InfectionBenign NeoplasmMalignant Neoplasm+4 more
Children's Oncology Group 177
Next Page